Demand for IVD and Targeted Therapeutics to Drive Companion Cancer Diagnostic Testing Market to USD 4.5 Billion by 2020 - iHealthcareAnalyst, Inc.
Companion Cancer Diagnostic Testing Market – Global Cancer Diseases Analysis and Forecast 2013-2020
Maryland Heights, MO, July 07, 2016 --(PR.com)-- Companion Cancer Diagnostic Testing Market – Global Cancer Diseases Analysis and Forecast 2013-2020, estimates the global companion diagnostic testing market to reach nearly USD 4.5 Billion in 2020, at a CAGR of 10% from 2016 to 2020 - iHealthcareAnalyst, Inc.
Visit the Companion Cancer Diagnostic Testing Market – Global Cancer Diseases Analysis and Forecast 2013-2020 report at http://www.ihealthcareanalyst.com/report/companion-diagnostics-market/
The emergence of targeted therapies in oncology brings an increased need for companion diagnostic tests. Companion diagnostics are medical devices that help physicians to decide the treatments and effective dosage for patients and which are tailored specifically to the patient. It is an in vitro device, which provides information that is essential for the safe and effective use of a corresponding drug or biological product. The companion diagnostic testing market report estimates the market size (Revenue USD million - 2013 to 2020) for market segmentation based on indication or disease type (breast cancer, colorectal cancer, gastric cancer, lung cancer, melanoma, etc.), and forecasts growth trends (CAGR% - 2016 to 2020). It also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent acquisitions and alliances.
The global companion diagnostic testing market is segmented as:
1. Indication (Cancer Type)
1.1. Breast Cancer
1.2. Colorectal Cancer
1.3. Gastric Cancer
1.4. Lung Cancer
1.5. Melanoma
1.6. Others (HIV, Thalassemia)
2. Geography (Region, Country)
2.1. North America (U.S., Canada)
2.2. Latin America (Brazil, Mexico, Rest of LA)
2.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4. Asia Pacific (Japan, China, India, Rest of APAC)
2.5. Rest of the World
3. Company Profiles
3.1. Abbott Laboratories
3.2. Agendia N.V.
3.3. Agilent Technologies, Inc.
3.4. BioGenex Laboratories Inc.
3.5. bioMérieux SA
3.6. GE Healthcare
3.7. Genomic Health, Inc.
3.8. F. Hoffmann-La Roche Ltd.
3.9. Qiagen N.V.
3.10. Resonance Health Analysis Services Pty Ltd.
3.11. Siemens Healthcare
3.12. Thermo Fisher Scientific (Life Technologies Corp.)
About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.
Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareranalyst.com
Website: http://www.ihealthcareanalyst.com
Visit the Companion Cancer Diagnostic Testing Market – Global Cancer Diseases Analysis and Forecast 2013-2020 report at http://www.ihealthcareanalyst.com/report/companion-diagnostics-market/
The emergence of targeted therapies in oncology brings an increased need for companion diagnostic tests. Companion diagnostics are medical devices that help physicians to decide the treatments and effective dosage for patients and which are tailored specifically to the patient. It is an in vitro device, which provides information that is essential for the safe and effective use of a corresponding drug or biological product. The companion diagnostic testing market report estimates the market size (Revenue USD million - 2013 to 2020) for market segmentation based on indication or disease type (breast cancer, colorectal cancer, gastric cancer, lung cancer, melanoma, etc.), and forecasts growth trends (CAGR% - 2016 to 2020). It also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent acquisitions and alliances.
The global companion diagnostic testing market is segmented as:
1. Indication (Cancer Type)
1.1. Breast Cancer
1.2. Colorectal Cancer
1.3. Gastric Cancer
1.4. Lung Cancer
1.5. Melanoma
1.6. Others (HIV, Thalassemia)
2. Geography (Region, Country)
2.1. North America (U.S., Canada)
2.2. Latin America (Brazil, Mexico, Rest of LA)
2.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4. Asia Pacific (Japan, China, India, Rest of APAC)
2.5. Rest of the World
3. Company Profiles
3.1. Abbott Laboratories
3.2. Agendia N.V.
3.3. Agilent Technologies, Inc.
3.4. BioGenex Laboratories Inc.
3.5. bioMérieux SA
3.6. GE Healthcare
3.7. Genomic Health, Inc.
3.8. F. Hoffmann-La Roche Ltd.
3.9. Qiagen N.V.
3.10. Resonance Health Analysis Services Pty Ltd.
3.11. Siemens Healthcare
3.12. Thermo Fisher Scientific (Life Technologies Corp.)
About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.
Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareranalyst.com
Website: http://www.ihealthcareanalyst.com
Contact
iHealthcareAnalyst, Inc.
Ana Aitawa
(314) 736-9294
http://www.ihealthcareanalyst.com/
Ana Aitawa
(314) 736-9294
http://www.ihealthcareanalyst.com/
Contact
Categories